Estimates of the national burden of respiratory syncytial virus in Kenyan children aged under 5 years, 2010-2018.
Bryan O NyawandaNickson MurungaNancy A OtienoGodfrey BigogoJoyce U NyiroElisabeth VodickaMarc BulterysD James NokesPatrick K MunywokiGideon O EmukulePublished in: BMC medicine (2023)
Our findings suggest a substantial disease burden due to RSV infection, particularly among younger children. Prioritizing development and use of maternal vaccines and affordable long-lasting monoclonal antibodies could help reduce this burden.